Acylin Therapeutics' Series A - II Round

Acylin Therapeutics raised a round of funding on June 04, 2012.

Aylin Therapeutics is a biotechnology company focused on developing inhibitors of cellular acylation, an enzymatic mechanism fundamental to the molecular pathology of cancer, metabolic disease, and ne…

Articles about Acylin Therapeutics' Series A - II Round: